Latest News
HOW DO I ACCESS MOUNJARO?
This information is about how the weight loss drug tirzepatide (Mounjaro®) will be prescribed to patients.
The local NHS is aiming for this drug to be available to those eligible later in the year but is paused whilst we set up local clinics for Derby and Derbyshire.
We are working across the local NHS to put in place community-based clinics to meet areas of greatest need.
This is being organised by the Integrated Care Board (ICB) which has the responsibility.
Please do not contact your GP if you think you are eligible as it will not be available in Derby and Derbyshire until later in the year.
The ICB will publish more information once a service has been set up explaining who can access it and how this can happen. Please click HERE for more information and updates
Policy Change to the Cervical Screening Programme
From 1 July 2025, routine cervical screening intervals will be extended from 3 to 5 years for
participants aged 25-49 who test negative after attending cervical screening on or after this
date.
Next test due dates will not be changed; individuals will be invited at the interval in which
they were advised of at the time of their last test.
Why are cervical screening intervals changing?
The Human Papillomavirus (HPV) causes nearly all cervical cancers. We now use a
test which is more sensitive and accurate than the previous method (smear test) to
look for HPV in your sample. This helps us offer a more personalised approach by
finding out who is at higher risk of developing the cervical cell changes that over time,
if left untreated, could lead to cervical cancer. This change from 3 to 5 yearly screening
is backed by robust scientific evidence – studies have shown that if you test negative
for HPV you are extremely unlikely to go on to develop cervical cancer within the next
10 years. So now we have this better test, you don’t need to be screened as often if
you don’t have HPV.
Will everyone move onto this new 5 yearly screening pathway
automatically?
No. Next test due dates will not be changed retrospectively; you will be invited at the
interval in which you were advised of at the time of your last test.
Only those who attend cervical screening on or after 1 July, and meet the clinical
criteria, will have their next test due date set at 5 years. NHS England made this
decision based on clinical advice from experts.
Those aged 50 to 64 are already invited every 5 years.
What happens if I test positive for HPV?
It’s important to remember that having HPV does not mean that you have or
will develop cervical cancer. It is a common virus that most people will have at some
point in their life without knowing, which usually goes away on its own. If HPV is found
in your sample and there are no cell changes, you are invited for screening again in 1
year.
If cell changes are found alongside HPV, you are referred directly to a hospital clinic
for a colposcopy to check the cervix more closely. Further follow up and treatment
will depend on the colposcopy findings.
I’ve heard that I will be invited for my cervical screening through the app,
but I don’t have it/don’t want it, what should I do?
From June 2025, you can receive cervical screening communications via the NHS
App. To benefit from this, please download the NHS app and make sure your
notifications are switched on. If you don’t wish to use the App, we’ll attempt to
contact you by text message. If we can’t reach you through these methods, we will
send a hard-copy letter through the post, so don’t worry, you won’t miss an invitation.
Update to Childhood Vaccination Schedule – From 1st July 2025
We’d like to let parents and carers know that from 1st July 2025, there will be a new national childhood vaccination schedule.
What’s changing?
A new routine vaccination appointment will now take place when your child is 18 months old. The schedule for both children born before and after 1.7.25 is shown below.
If you have any queries regarding the new schedule please book an appointment to speak to a practice nurse.
Routine childhood immunisations
Age due | Vaccines that protect against | Vaccine given | |
---|---|---|---|
8 weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | DTaP/IPV/Hib/HepB (6 in 1 vaccine) | |
Meningococcal group B (MenB) | MenB | ||
Rotavirus gastroenteritis | Rotavirus | ||
12 weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | DTaP/IPV/Hib/HepB (6 in 1 vaccine) | |
MenB | MenB | ||
Rotavirus | Rotavirus | ||
16 weeks old | Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B | DTaP/IPV/Hib/HepB (6 in 1 vaccine) | |
Pneumococcal (13 serotypes) • if received pneumococcal at 12 weeks give Men B |
PCV | ||
One year old (on or after the child’s first birthday) | Born before 1 July 2024 | Born on or after 1 July 2024 | |
Pneumococcal | Pneumococcal | PCV | |
Measles, mumps, rubella | Measles, mumps, rubella | MMR | |
MenB | MenB | MenB | |
Hib/MenC (if Hib/MenC exhausted give DTaP/Hib/IPV/HepB) | Hib/MenC | ||
18 months old | Born before 1 July 2024 | Born on or after 1 July 2024 | |
No appointment | DTaP/IPV/Hib/HepB | DTaP/IPV/Hib/HepB | |
Measles, mumps, rubella | MMR | ||
3 years 4 months old or soon after | Born before 1 July 2024 | Born on or after 1 July 2024 | |
Diphtheria, tetanus, pertussis and polio | Diphtheria, tetanus, pertussis and polio | dTaP/IPV | |
Measles, mumps, rubella | MMR |
Page created: 25 June 2025